Christina Pohlman: Anticoagulants and Bone Health – APS Awareness Month Day 23
Christina Pohlman, CEO and Co-Founder of APS Foundation of America, shared a post on LinkedIn:
“Anticoagulants and Bone Health – APS Awareness Month Day 23
Anticoagulants are medications that help prevent blood clots, but there’s a growing conversation about their impact on bone health.
While these medications are life-saving for many, they can have side effects that might affect your bones over time.
Evidence suggests that long-term use of certain anticoagulants, especially warfarin, may be linked to reduced bone density, increasing the risk of fractures.
It’s essential to balance the need for anticoagulation with maintaining bone health, especially for individuals at a higher risk of osteoporosis.
If you’re on anticoagulant therapy, it’s a good idea to discuss with your healthcare provider about monitoring your bone health.
They might recommend lifestyle modifications, like increased calcium and vitamin D intake, regular weight-bearing exercises, or possibly even discussing other anticoagulant options.
Your bones play a critical role in overall health, so always stay informed and proactive about your bone density alongside your anticoagulant treatment.”

Other posts featuring Christina Pohlman on Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments